Design Therapeutics Inc
NASDAQ:DSGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Design Therapeutics Inc
NASDAQ:DSGN
|
US |
|
Maxim Power Corp
F:MP9
|
CA |
|
I
|
Intesa Sanpaolo SpA
LSE:0HBC
|
IT |
|
C
|
CIMIC Group Ltd
F:LTH
|
AU |
|
M
|
MGX Minerals Inc
CNSX:XMG
|
CA |
|
Ciputra Development Tbk PT
IDX:CTRA
|
ID |
|
Ecora Resources PLC
TSX:ECOR
|
UK |
|
A
|
Attendo AB (publ)
F:7AT
|
SE |
|
CoStar Group Inc
NASDAQ:CSGP
|
US |
|
ING Bank Slaski SA
F:6GF
|
PL |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
K
|
Kubota Corp
OTC:KUBTF
|
JP |
|
F J Benjamin Holdings Ltd
SGX:F10
|
SG |
|
P
|
Pappajack Bhd
KLSE:PPJACK
|
MY |
|
Franchise Brands PLC
LSE:FRAN
|
UK |
|
Bank Raya Indonesia Tbk PT
IDX:AGRO
|
ID |
|
Real Brands Inc
OTC:RLBD
|
US |
|
4Aim Societa di Investimento per Azioni a Capitale Fisso
MIL:4AIM
|
IT |
|
P
|
Powerhouse Energy Group PLC
F:BT81
|
UK |
|
Multipolar Tbk PT
F:MLQ2
|
ID |
|
Glassbridge Enterprises Inc
OTC:GLAE
|
US |
|
L
|
Linde PLC
DUS:LIN
|
UK |
Wall St Price Targets
DSGN Price Targets Summary
Design Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
DSGN is 21.42 USD with a low forecast of 20.2 USD and a high forecast of 23.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DSGN's stock price target?
Price Target
21.42
USD
According to Wall Street analysts, the average 1-year price target for
DSGN is 21.42 USD with a low forecast of 20.2 USD and a high forecast of 23.1 USD.